FDA clearsAI-assisted CCTA software that assesses plaques for signs of heart disease
Cardiovascular Business CaRi-Heart was built to evaluate CCTA images for signs of coronary inflammation and provide clinicians with in-depthriskscores. When it does gain …
Read the original at cardiovascularbusiness.com ↗
- Topics
- Healthcare
- Mentions
- FDA
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”